Penn Mutual Asset Management - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 115 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.07 and the average weighting 0.6%.

Quarter-by-quarter ownership
Penn Mutual Asset Management ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$646,861
-3.0%
62,8020.0%1.38%
-3.4%
Q1 2024$666,957
+16.3%
62,8020.0%1.42%
+222.2%
Q4 2023$573,382
-12.0%
62,8020.0%0.44%
-27.7%
Q3 2023$651,257
-27.6%
62,8020.0%0.61%
-24.7%
Q2 2023$899,325
+100.6%
62,8020.0%0.81%
+90.8%
Q1 2023$448,406
-36.4%
62,8020.0%0.42%
-46.0%
Q4 2022$704,638
-26.8%
62,802
-27.8%
0.79%
-37.5%
Q3 2022$963,000
+31.2%
86,9400.0%1.26%
+27.4%
Q2 2022$734,000
-38.0%
86,9400.0%0.99%
-27.9%
Q1 2022$1,183,000
-57.6%
86,9400.0%1.37%
-68.9%
Q3 2021$2,791,000
-5.2%
86,9400.0%4.41%
+20.0%
Q2 2021$2,943,000
-9.9%
86,9400.0%3.68%
-0.3%
Q1 2021$3,265,000
+13.1%
86,9400.0%3.69%
+44.6%
Q4 2020$2,888,000
-9.4%
86,9400.0%2.55%
-43.3%
Q3 2020$3,188,000
+11.4%
86,9400.0%4.50%
+53.8%
Q2 2020$2,861,00086,9402.92%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 7,464,572$76,885,09222.93%
Propel Bio Management, LLC 869,927$8,960,2485.81%
Catalys Pacific, LLC 721,962$7,436,2085.61%
Checkpoint Capital L.P. 875,000$9,012,5005.43%
Frazier Life Sciences Management, L.P. 10,109,279$104,125,5744.87%
Carlyle Group Inc. 3,496,808$35,842,2823.40%
Decheng Capital LLC 850,000$8,755,0002.68%
Saturn V Capital Management LP 593,306$6,111,0522.31%
ORACLE INVESTMENT MANAGEMENT INC 225,000$2,317,5002.16%
Ghost Tree Capital, LLC 600,000$6,180,0001.94%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders